Skip to content
WeighLab
Menu
Ranked #13 · Grade B

Curex review

Identical $199 on both molecules nationwide, with an oral route and LegitScript verification — simple, predictable, verified.

Visit Curex Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$199/mo
Tirzepatide
$199/mo
Coverage
All 50 states
Brand-name
Compounded only

Semaglutide · modeled / year

$2,388

Tirzepatide · modeled / year

$2,388

The Index scorecard

Curex scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month78/100
Price Transparency87/100
Nationwide Access96/100
Formulation Options84/100
Clinical Oversight87/100
Contract Flexibility80/100

Where the value is

  • Identical $199 price on both molecules makes cost modeling trivial
  • Nationwide all-50 access plus an oral/sublingual route
  • LegitScript-certified

The tradeoffs

  • $199 is mid-market, beaten by several all-50 rivals on raw cost
  • No FDA-approved brand-name access

The bottom line

Best for: People who want one flat price across both molecules, an oral option, and a verified pharmacy nationwide. Identical $199 on both molecules nationwide, with an oral route and LegitScript verification — simple, predictable, verified.

Ranked #13 of 25 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 24 other providers we've modeled, in Cost-Efficiency Index order.

Pricing, states and verification reflect Curex's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Curex's site. Not medical advice; see our disclosure.

← Back to the value leaderboard